Trending
Eli Lilly Grants Retatrutide Compassionate Use to 79-Year-Old Patient: A Landmark Obesity Drug Decision
A significant moment in pharmaceutical history as Eli Lilly grants extraordinary access to its investigational triple-hormone receptor agonist.
Read Full Story